MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Carcinoma, Papillary

(UMLS:C0007133)

Definition:: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
UMLS ID:: C0007133
MeSH ID:: D002291

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.470.200.360|C04.557.470.700.360

Synonym(s)

Carcinoma, Papillary

Papillary Carcinoma

Papillary carcinoma

Papillary carcinoma NOS

Papillary carcinoma, NOS

carcinoma papillary

papillary carcinoma

papillary carcinomas

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Methylenebis(chloroaniline)		722185	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Squamous cell carcinoma	71%
2	Basal cell carcinoma	58.1%
3	Carcinoma, Basal Cell	58.1%
4	Bowen's Disease	52.8%
5	Cystadenocarcinoma	49%
6	Mucoepidermoid Carcinoma	49%
7	Adenocarcinoma	47.3%
8	Carcinoma in Situ	47.3%
9	Carcinoma, Transitional Cell	47.3%
10	Papilloma	47.3%
11	Papillomatosis	47.3%
12	Carcinoma, Large Cell	47.3%
13	Carcinoma, Small Cell	47.3%
14	Adenoma	45.7%
15	Cystadenoma	45.2%
16	Mesothelioma	45.2%
17	Carcinoma, Ehrlich Tumor	44.6%
18	Carcinoma, Lewis Lung	44.6%
19	Neoplasms, Neuroepithelial	42.9%
20	Gliomatosis cerebri	42.9%
21	Acanthoma	40.7%
22	Carcinoma, Lobular	36.1%
23	Adenoid Cystic Carcinoma	35.3%
24	Adenocarcinoma, Clear Cell	35.3%
25	Cholangiocarcinoma	35.3%
26	Cervical Intraepithelial Neoplasia	35.3%
27	leukemia	33.3%
28	Neoplasms, Germ Cell and Embryonal	33.3%
29	Germ Cell Cancer	33.3%
30	Carcinoid Tumor	32.6%
31	Pseudomyxoma Peritonei	30.1%
32	Adenomatosis, Pulmonary	30.1%
33	Adenomatous Polyps	30.1%
34	Neuroectodermal Tumors	29.5%
35	Adenoma, Acidophil	29.5%
36	Ganglioneuroma	29.5%
37	Glioma	29.5%
38	Malignant Glioma	29.5%
39	Klatskin Tumor	29.3%
40	Medulloblastoma	28.6%
41	Adenofibroma	28.5%
42	Fibroadenoma	28.5%
43	Choriocarcinoma	27.5%
44	Malignant Carcinoid Syndrome	27%
45	Histiocytic Disorders, Malignant	25%
46	Carcinosarcoma	24.4%
47	Hemangiosarcoma	24.4%
48	lymphangiosarcoma	24.4%
49	melanoma	23.2%
50	Astrocytoma	22.9%
51	Ependymoma	22.9%
52	oligodendroglioma	22.9%
53	Ganglioglioma	22.9%
54	gliosarcoma	22.9%
55	Anaplastic astrocytoma	22.9%
56	Anaplastic Oligodendroglioma	22.9%
57	Carcinoma	22.8%
58	Epithelioma	22.8%
59	Carcinoma, Papillary	22.6%
60	Meningioma	21.1%
61	Hamartoma	20.9%
62	Neoplasms, Hormone-Dependent	20.9%
63	Neoplasms, Multiple Primary	20.9%
64	Paraneoplastic Syndromes	20.9%
65	Precancerous Conditions	20.9%
66	Neoplasms, Second Primary	20.9%
67	Carcinoid Heart Disease	20.6%
68	Carcinoma, Pancreatic Ductal	20.4%
69	Carcinoma 256, Walker	20.3%
70	Lymphoma	20%
71	Basal Cell Nevus Syndrome	19.9%
72	Glioblastoma	19.7%
73	Neuroblastoma	19.7%
74	Glioblastoma Multiforme	19.7%
75	Ameloblastoma	19.6%
76	Angiokeratoma	19.6%
77	Chordoma	19.6%
78	Hemangioma	19.6%
79	hemangiopericytoma	19.6%
80	Lymphangioma	19.6%
81	Mesenchymoma	19.6%
82	Nevus	19.6%
83	Teratoma	19.6%
84	Hepatoblastoma	19.6%
85	Mixed Tumor, Mullerian	19.6%
86	Germinoma	19.6%
87	Teratocarcinoma	19.6%
88	Angiofibroma	19.6%
89	Composite Lymphoma	19.6%
90	Sarcoma	19.6%
91	Leukemia, Plasma Cell	19.5%
92	Chondrosarcoma	19.4%
93	Craniopharyngioma	19.4%
94	leiomyosarcoma	19.4%
95	liposarcoma	19.4%
96	synovial sarcoma	19.4%
97	Neuroectodermal Tumor, Melanotic	19.4%
98	Angiomyolipoma	19.4%
99	Clear Cell Sarcoma of Soft Tissue	19.4%
100	Alveolar Soft Part Sarcoma	19.4%
101	Neuroendocrine Tumors	19.4%
102	Sarcoma, Myeloid	19.4%
103	Carcinoma, Ovarian Epithelial	19.3%
104	Trophoblastic Neoplasms	18.7%
105	Leukemia, Experimental	18.5%
106	Dermoid Cyst	18.2%
107	Retinoblastoma	18.2%
108	Ganglioneuroblastoma	18.1%
109	Hepatocellular Adenoma	17.4%
110	Neurilemmoma	17.3%
111	Hutchinson's Melanotic Freckle	17.3%
112	Melanoma, Amelanotic	17.3%
113	Melanoma, Experimental	17.2%
114	Fibrosarcoma	16.9%
115	Osteosarcoma	16.9%
116	Nasopharyngeal carcinoma	16.6%
117	Adrenocortical carcinoma	16.5%
118	Cyst	15.8%
119	Neoplastic Processes	15.8%
120	Neoplastic Syndromes, Hereditary	15.8%
121	Pregnancy Complications, Neoplastic	15.8%
122	Leukemia, Radiation-Induced	15.6%
123	Malignant Fibrous Histiocytoma	15.6%
124	Neoplasms, Experimental	15.5%
125	Prolactinoma	14.8%
126	Growth Hormone-Secreting Pituitary Adenoma	14.8%
127	Plasmacytoma	14.8%
128	Malignant histiocytosis	14.6%
129	Leukemia L1210	14.6%
130	Leukemia P388	14.6%
131	Histiocytic sarcoma	14.6%
132	Vipoma	14.6%
133	Sarcoma, Experimental	14.5%
134	Endometrial Stromal Sarcoma	14.4%
135	Renal Cell Carcinoma	14.4%
136	Paraganglioma	14.4%
137	Rhabdomyosarcoma	14.4%
138	Giant Cell Tumor of Bone	14.4%
139	Papillary Renal Cell Carcinoma	14.4%
140	Thymoma	14.4%
141	Carcinoma, Endometrioid	14.1%
142	Gastrinoma	13.4%
143	Glucagonoma	13.4%
144	Dermatofibrosarcoma	13.2%
145	Dermatofibrosarcoma Protuberans	13.2%
146	Phyllodes Tumor	12.9%
147	Dysgerminoma	12.9%
148	Hemangioendothelioma	12.9%
149	Lipoma	12.9%
150	Myoma	12.9%
151	Myxoma	12.9%
152	Neuroma	12.9%
153	Seminoma	12.9%
154	Angiolipoma	12.9%
155	Myelolipoma	12.9%
156	Neoplasms, Bone Tissue	12.9%
157	Neoplasms, Fibrous Tissue	12.9%
158	Smooth Muscle Tumor	12.9%
159	Desmoplastic Small Round Cell Tumor	12.9%
160	Lymphangioleiomyomatosis	12.9%
161	Chondroma	12.9%
162	Enchondroma	12.9%
163	Multiple Endocrine Neoplasia	12.6%
164	Neoplasms, Radiation-Induced	12.4%
165	Sarcoma 180	12.1%
166	Pheochromocytoma	12%
167	Alveolar rhabdomyosarcoma	12%
168	Hodgkin Disease	11.7%
169	Lymphoma, Non-Hodgkin	11.7%
170	Neurofibrosarcoma	11.6%
171	Abdominal Neoplasms	11.1%
172	Erythroplasia	11.1%
173	Follicular cyst	11.1%
174	Head and Neck Neoplasms	11.1%
175	Mucocele	11.1%
176	Pilonidal Cyst	11.1%
177	Soft Tissue Neoplasms	11.1%
178	Thoracic Neoplasms	11.1%
179	Thyroglossal Cyst	11.1%
180	Synovial Cyst	11.1%
181	Aberrant Crypt Foci	11.1%
182	Optic Nerve Glioma	11.1%
183	insulinoma	10.8%
184	Paraneoplastic Encephalomyelitis	10.8%
185	Mammary Neoplasms, Experimental	10.6%
186	Lymphomatoid Granulomatosis	10.3%
187	Nephroblastoma	10.1%
188	Adenomatous Polyposis Coli	9.8%
189	Primary amyloidosis	9.8%
190	Leukemia, Myelomonocytic, Chronic	9.7%
191	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.7%
192	fibroma	9.6%
193	Fibromatosis	9.6%
194	Osteoblastoma	9.6%
195	Osteoma	9.6%
196	Rhabdomyoma	9.6%
197	Chondromatosis	9.6%
198	Hemangioblastoma	9.6%
199	Lymphoma, Extranodal NK-T-Cell	9.6%
200	Tuberous Sclerosis	9.2%
201	Digestive System Neoplasms	8.8%
202	Endocrine Gland Neoplasms	8.8%
203	Eye Neoplasms	8.8%
204	Nervous System Neoplasms	8.8%
205	Acoustic Neuroma	8.7%
206	Bone neoplasms	8.5%
207	Leukoplakia	8.5%
208	Lymphocele	8.5%
209	Pancreatic Cyst	8.5%
210	Skin Neoplasms	8.5%
211	Hematologic Neoplasms	8.5%
212	Mesoblastic Nephroma	8.5%
213	Barrett Esophagus	8.3%
214	Breast Cyst	8.3%
215	Hydatidiform Mole	8.3%
216	Actinic keratosis	8.3%
217	Mediastinal Cyst	8.3%
218	Neoplasm Invasiveness	8.3%
219	Neoplasm Metastasis	8.3%
220	Neoplasm Recurrence, Local	8.3%
221	Parovarian Cyst	8.3%
222	Pericardial Cyst	8.3%
223	Splenic Neoplasms	8.3%
224	Thymic Cyst	8.3%
225	Carcinogenesis	8.3%
226	Myxoid cyst	8.3%
227	Metastasis	8.3%
228	Fibromatosis, Aggressive	8%
229	Fibromatosis, Abdominal	8%
230	Mastocytosis	7.9%
231	Sturge-Weber Syndrome	7.9%
232	Gastrointestinal Stromal Tumors	7.8%
233	Hemangioma, Cavernous	7.8%
234	Leukemia, T-Cell	7.7%
235	Leukemia, B-Cell	7.7%
236	neurofibroma	7.7%
237	Lymphoma, Follicular	7.7%
238	T-Cell Lymphoma	7.7%
239	Mantle cell lymphoma	7.7%
240	Multiple Endocrine Neoplasia Type 1	7.5%
241	Waldenstrom Macroglobulinemia	7.4%
242	Multiple Myeloma	7.4%
243	Mastocytoma	7.3%
244	Mastocytosis, Systemic	7.2%
245	Leukemia, Myeloid, Chronic-Phase	7.2%
246	Parathyroid Neoplasms	6.7%
247	Peritoneal Neoplasms	6.7%
248	Thyroid Neoplasm	6.7%
249	Thyroid carcinoma	6.7%
250	Liver Neoplasms, Experimental	6.6%
251	Corpus Luteum Cyst	6.6%
252	Ovarian Cysts	6.6%
253	Retroperitoneal Neoplasms	6.5%
254	granulosa cell tumor	6.4%
255	Pancreatic Neoplasm	5.8%
256	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	5.8%
257	Leukemia, Large Granular Lymphocytic	5.8%
258	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	5.8%
259	Lymphoma, T-Cell, Cutaneous	5.7%
260	Lymphoma, AIDS-Related	5.7%
261	Enteropathy-Associated T-Cell Lymphoma	5.7%
262	Primary Effusion Lymphoma	5.7%
263	Choledochal Cyst	5.6%
264	Tracheal Neoplasms	5.6%
265	Peutz-Jeghers Syndrome	5.5%
266	Leukoplakia, Oral	5.5%
267	Paraneoplastic Cerebellar Degeneration	5.4%
268	Leydig Cell Tumor	5.1%
269	Mouth Neoplasms	5%
270	Central Nervous System Neoplasms	5%
271	Vascular Neoplasms	5%
272	Thymus Neoplasms	5%
273	Dupuytren Contracture	4.9%
274	Genital Neoplasms, Female	4.9%
275	Pancreatic Pseudocyst	4.9%
276	Lymphatic Metastasis	4.9%
277	Neoplasms, Unknown Primary	4.9%
278	Leukemic Infiltration	4.9%
279	Breast Neoplasms, Male	4.9%
280	Neoplasm Micrometastasis	4.9%
281	Triple Negative Breast Neoplasms	4.9%
282	Urticaria Pigmentosa	4.8%
283	Mycosis Fungoides	4.8%
284	Lymphomatoid Papulosis	4.8%
285	Plasmablastic lymphoma	4.8%
286	Esophageal Neoplasms	4.7%
287	Denys-Drash Syndrome	4.7%
288	Limbic Encephalitis	4.7%
289	Thyroid Nodule	4.3%
290	Lambert-Eaton Myasthenic Syndrome	4.1%
291	Testicular Neoplasms	4.1%
292	Burkitt Lymphoma	4.1%
293	Adrenal Gland Neoplasms	4.1%
294	Gastrointestinal Neoplasms	4.1%
295	Genital Neoplasms, Male	4.1%
296	Liver neoplasms	4.1%
297	Uveal Neoplasms	4.1%
298	Urologic Neoplasms	4%
299	Sebaceous Gland Neoplasms	3.9%
300	Spinal Neoplasms	3.9%
301	Bone Marrow Neoplasms	3.9%
302	Polycystic Ovary Syndrome	3.9%
303	Opsoclonus-Myoclonus Syndrome	3.7%
304	Sezary Syndrome	3.4%
305	Xeroderma Pigmentosum	3.3%
306	Myelitis, Transverse	3.3%
307	Meningeal Neoplasms	3.3%
308	Nose Neoplasms	3%
309	Palatal Neoplasms	2.8%
310	ovarian neoplasm	2.8%
311	Pituitary Adenoma	2.7%
312	Pituitary Neoplasms	2.7%
313	Ear Neoplasms	2.7%
314	Eyelid Neoplasms	2.7%
315	Lung Neoplasms	2.7%
316	Pleural Neoplasms	2.7%
317	Cell Transformation, Viral	2.6%
318	Brain Neoplasms	2.6%
319	Salivary Gland Neoplasms	2.6%
320	Spinal Cord Neoplasms	2.6%
321	Tongue Neoplasms	2.6%
322	Uterine Neoplasms	2.6%
323	Vaginal Neoplasms	2.6%
324	Vulvar Neoplasms	2.6%
325	Uterine Cancer	2.6%
326	Fallopian Tube Neoplasms	2.6%
327	Meningeal Carcinomatosis	2.4%
328	Pharyngeal Neoplasms	2.3%
329	Central Nervous System Cysts	2.2%
330	Bile Duct Neoplasms	2.2%
331	gallbladder neoplasm	2.2%
332	Intestinal Neoplasms	2.2%
333	Penile Neoplasms	2.2%
334	Prostatic Neoplasms	2.2%
335	Stomach Neoplasms	2.2%
336	Zollinger-Ellison syndrome	2.2%
337	Polycythemia Vera	2.2%
338	Bronchial Neoplasms	2%
339	Multiple Pulmonary Nodules	2%
340	Laryngeal neoplasm	2%
341	Supratentorial Neoplasms	1.9%
342	Endometrial Neoplasms	1.9%
343	Bladder Neoplasm	1.9%
344	Kidney Neoplasm	1.9%
345	Ureteral Neoplasms	1.9%
346	Urethral Neoplasms	1.9%
347	Hypopharyngeal Neoplasms	1.6%
348	Pleural Effusion, Malignant	1.6%
349	Hypopharyngeal Cancer	1.6%
350	Parotid Neoplasms	1.6%
351	Prostatic Neoplasms, Castration-Resistant	1.6%
352	Nelson Syndrome	1.6%
353	Brain Stem Neoplasms	1.6%
354	Choroid Plexus Papilloma	1.4%
355	Cecal Neoplasms	1.4%
356	Duodenal Neoplasms	1.4%
357	Tonsillar Neoplasms	1.3%
358	Cerebellar Neoplasms	1.3%
359	Nasopharyngeal Neoplasms	1.2%
360	Colorectal Neoplasms	1.2%
361	Radicular Cyst	1.1%
362	Appendiceal Neoplasms	1.1%
363	Colonic Neoplasms	1.1%
364	Rectal Neoplasms	1.1%
365	Paranasal Sinus Neoplasms	1.1%
366	Maxillary Sinus Neoplasms	0.9%
367	Anus Neoplasms	0.9%
368	Sigmoid Neoplasms	0.9%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234